Recent Lessons

Show all results for ""

Feature Overview

Ace your exams with our all-in-one platform for creating and sharing quizzes and tests.

Quizzes

Create quizzes and tests automatically from your content using AI.

Flashcards

Automatically turn your notes into digital flashcards.

Share, Export & Embed

Share with classmates or export to Excel and your learning management system.

Stats & Reporting

Auto-grading quizzes and tests with detailed stats and reports.

Mobile Apps

The smarter way to study – wherever you are.

Pricing

Search...

10 Questions

0 Views

Pulmonary Hypertension Management

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary consideration when selecting a calcium channel blocker for Class II PAH?

The patient's weight

The patient's age

The patient's heart rate at baseline (correct)

The patient's blood pressure at baseline

What is the most common adverse effect of inhaled iloprost?

Cough

Erythema

Nausea

Jaw pain (correct)

Which of the following is NOT a consideration when using prostanoids for PAH?

Patient's blood type (correct)

Route of administration

Patient's heart rate at baseline

Dose titration

What is the primary advantage of B-type natriuretic peptide (BNP) monitoring in PAH treatment?

It helps to monitor treatment response Signup and view all the answers

Which of the following is a common adverse effect of endothelin receptor antagonists?

All of the above Signup and view all the answers

What is the recommended dose of inhaled iloprost for Class III–IV PAH?

2.5 mcg/inhalation Signup and view all the answers

What is the primary consideration when using calcium channel blockers empirically in PAH?

The patient's response to acute vasodilatory testing Signup and view all the answers

Which of the following is a common adverse effect of treprostinil?

All of the above Signup and view all the answers

What is the primary advantage of endothelin receptor antagonists in PAH treatment?

They slow disease progression Signup and view all the answers

What is the recommended dose of epoprostenol for PAH?

2–40 ng/kg/minute IV Signup and view all the answers